Literature DB >> 8509785

Mortality from Parkinson's disease in England and Wales 1921-89.

C E Clarke1.   

Abstract

Mortality from Parkinson's disease in England and Wales was re-examined using published government statistics. The 300% increase in the crude mortality rate between 1921 and 1989 was largely attributable to the increase in the elderly population who suffer a higher prevalence of the disease. The dramatic fall in 1940 and rise in 1984 were artefacts caused by changes in certification. Age-specific mortality fell after 1940 in all groups below 70 years and in both sexes, but increased in those over 75 years. Analysis by birth cohort showed a progressive decline in mortality at younger ages with successive cohorts but stable mortality in the elderly. Younger patients were probably misclassified cases of "late-onset" Parkinsonism following encephalitis lethargica who can be differentiated from older cases of idiopathic Parkinson's disease. Mortality decreased in all age groups in the 1970s but then increased in the early 1980s. This is comparable to trends in the United States and Scandinavia and suggests that the beneficial effects of levodopa delay death for several years.

Entities:  

Mesh:

Year:  1993        PMID: 8509785      PMCID: PMC489621          DOI: 10.1136/jnnp.56.6.690

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  12 in total

1.  Longitudinal Gompertzian analysis of Parkinson's disease mortality in the U.S., 1955-1986: the dramatic increase in overall mortality since 1980 is the natural consequence of deterministic mortality dynamics.

Authors:  J E Riggs
Journal:  Mech Ageing Dev       Date:  1990-09       Impact factor: 5.432

2.  PARKINSONISM BEFORE AND SINCE THE EPIDEMIC OF ENCEPHALITIS LETHARGICA.

Authors:  R C DUVOISIN; M D YAHR; M D SCHWEITZER; H H MERRITT
Journal:  Arch Neurol       Date:  1963-09

3.  Parkinson's disease mortality: preliminary report.

Authors:  T A Treves
Journal:  Adv Neurol       Date:  1990

4.  Changing mortality from Parkinson's disease.

Authors:  T P Flaten
Journal:  Neurology       Date:  1991-02       Impact factor: 9.910

5.  Effect of L-dopa on course of Parkinson's disease.

Authors:  L Curtis; A J Lees; G M Stern; M G Marmot
Journal:  Lancet       Date:  1984-07-28       Impact factor: 79.321

6.  Parkinson's disease in epidemiologic perspective.

Authors:  I I Kessler
Journal:  Adv Neurol       Date:  1978

7.  Parkinsonism: onset, progression and mortality.

Authors:  M M Hoehn; M D Yahr
Journal:  Neurology       Date:  1967-05       Impact factor: 9.910

8.  Two decades of increasing mortality from Parkinson's disease among the US elderly.

Authors:  D E Lilienfeld; E Chan; J Ehland; J Godbold; P J Landrigan; G Marsh; D P Perl
Journal:  Arch Neurol       Date:  1990-07

9.  Parkinson's disease: progression and mortality.

Authors:  M M Hoehn
Journal:  Adv Neurol       Date:  1987

10.  Could Parkinson's disease follow intra-uterine influenza?: a speculative hypothesis.

Authors:  C Mattock; M Marmot; G Stern
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-06       Impact factor: 10.154

View more
  12 in total

Review 1.  Late-stage Parkinson disease.

Authors:  Miguel Coelho; Joaquim J Ferreira
Journal:  Nat Rev Neurol       Date:  2012-07-10       Impact factor: 42.937

Review 2.  How far are we in understanding the cause of Parkinson's disease?

Authors:  Y Ben-Shlomo
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-07       Impact factor: 10.154

Review 3.  Parkinson's disease.

Authors:  J R Playfer
Journal:  Postgrad Med J       Date:  1997-05       Impact factor: 2.401

Review 4.  Parkinson's disease.

Authors:  C D Marsden
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-06       Impact factor: 10.154

Review 5.  Has drug therapy changed the natural history of Parkinson's disease?

Authors:  C E Clarke
Journal:  J Neurol       Date:  2010-11       Impact factor: 4.849

6.  Late-stage Parkinson's disease: the Barcelona and Lisbon cohort.

Authors:  Miguel Coelho; Maria J Marti; Eduardo Tolosa; Joaquim J Ferreira; Francesc Valldeoriola; Mário Rosa; Cristina Sampaio
Journal:  J Neurol       Date:  2010-04-22       Impact factor: 4.849

7.  The Demise of Poskanzer and Schwab's Influenza Theory on the Pathogenesis of Parkinson's Disease.

Authors:  Danny Estupinan; Sunina Nathoo; Michael S Okun
Journal:  Parkinsons Dis       Date:  2013-06-11

8.  The rise of mortality from mental and neurological diseases in Europe, 1979-2009: observational study.

Authors:  Johan P Mackenbach; Marina Karanikolos; Caspar W N Looman
Journal:  BMC Public Health       Date:  2014-08-13       Impact factor: 3.295

9.  Excessive early-life dietary exposure: a potential source of elevated brain iron and a risk factor for Parkinson's disease.

Authors:  Dominic J Hare; Bárbara Rita Cardoso; Erika P Raven; Kay L Double; David I Finkelstein; Ewa A Szymlek-Gay; Beverley-Ann Biggs
Journal:  NPJ Parkinsons Dis       Date:  2017-01-05

Review 10.  Epidemiology of Parkinson's disease.

Authors:  C M Tanner; S M Goldman
Journal:  Neurol Clin       Date:  1996-05       Impact factor: 3.806

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.